Abstract
Virus-like particle (VLP)-based vaccines have been in the market since decades for preventing viral infection and have proven their usefulness also in other areas of biotechnology. Here, we describe in detail simple small-scale production and purification procedures for the generation of hepatitis B surface antigen (HBsAg) VLPs using Pichia pastoris as expression host. This protocol may also be applicable with variations to other HBsAg-based VLPs additionally carrying antigens of other pathogens.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Cregg JM, Tschopp JF, Stillman C, Siegel R, Akong M, Craig WS et al (1987) High-level expression and efficient assembly of hepatitis B surface antigen in the methylotrophic yeast, Pichia pastoris. Nat Biotechnol 5:479–485
Kushnir N, Streatfield SJ, Yusibov V (2012) Virus-like particles as a highly efficient vaccine platform: diversity of targets and production systems and advances in clinical development. Vaccine 31:58–83
Boigard H, Alimova A, Martin GR, Katz A, Gottlieb P, Galarza JM (2017) Zika virus-like particle (VLP) based vaccine. PLoS Negl Trop Dis 11:e0005608
Meireles LC, Marinho RT, Van Damme P (2015) Three decades of hepatitis B control with vaccination. World J Hepatol 7:2127–2132
Roldao A, Mellado MC, Castilho LR, Carrondo MJ, Alves PM (2010) Virus-like particles in vaccine development. Expert Rev Vaccines 9:1149–1176
Zhao Q, Li S, Yu H, Xia N, Modis Y (2013) Virus-like particle-based human vaccines: quality assessment based on structural and functional properties. Trends Biotechnol 31:654–663
Khetarpal N, Poddar A, Nemani SK, Dhar N, Patil A, Negi P et al (2013) Dengue-specific subviral nanoparticles: design, creation and characterization. J Nanobiotechnology 11:15
Nardin EH, Oliveira GA, Calvo-Calle JM, Wetzel K, Maier C, Birkett AJ et al (2004) Phase I testing of a malaria vaccine composed of hepatitis B virus core particles expressing Plasmodium falciparum circumsporozoite epitopes. Infect Immun 72:6519–6527
Zhang L, Lua LH, Middelberg AP, Sun Y, Connors NK (2015) Biomolecular engineering of virus-like particles aided by computational chemistry methods. Chem Soc Rev 44:8608–8618
Kim HJ, Kim HJ (2017) Yeast as an expression system for producing virus-like particles: what factors do we need to consider? Lett Appl Microbiol 64:111–123
Wampler DE, Lehman ED, Boger J, McAleer WJ, Scolnick EM (1985) Multiple chemical forms of hepatitis B surface antigen produced in yeast. Proc Natl Acad Sci U S A 82:6830–6834
Biemans R, Thines D, Petre-Parent B, De Wilde M, Rutgers T, Cabezon T (1992) Immunoelectron microscopic detection of the hepatitis B virus major surface protein in dilated perinuclear membranes of yeast cells. DNA Cell Biol 11:621–626
Gurramkonda C, Adnan A, Gabel T, Lünsdorf H, Ross A, Nemani SK et al (2009) Simple high-cell density fed-batch technique for high-level recombinant protein production with Pichia pastoris: application to intracellular production of hepatitis B surface antigen. Microb Cell Factories 8:13
Vanz AL, Lünsdorf H, Adnan A, Nimtz M, Gurramkonda C, Khanna N et al (2012) Physiological response of Pichia pastoris GS115 to methanol-induced high level production of the hepatitis B surface antigen: catabolic adaptation, stress responses, and autophagic processes. Microb Cell Factories 11:103
Gurramkonda C, Zahid M, Nemani SK, Adnan A, Gudi SK, Khanna N et al (2013) Purification of hepatitis B surface antigen virus-like particles from recombinant Pichia pastoris and in vivo analysis of their immunogenic properties. J Chromatogr B 940:104–111
Zahid M, Lünsdorf H, Rinas U (2015) Assessing stability and assembly of the hepatitis B surface antigen into virus-like particles during down-stream processing. Vaccine 33:3739–3745
Vassileva A, Chugh DA, Swaminathan S, Khanna N (2001) Effect of copy number on the expression levels of hepatitis B surface antigen in the methylotrophic yeast Pichia pastoris. Protein Expr Purif 21:71–80
Bardiya N (2006) Expression in and purification of Hepatitis B surface antigen (S-protein) from methylotrophic yeast Pichia pastoris. Anaerobe 12:194–203
Ottone S, Nguyen X, Bazin J, Berard C, Jimenez S, Letourneur O (2007) Expression of hepatitis B surface antigen major subtypes in Pichia pastoris and purification for in vitro diagnosis. Protein Expr Purif 56:177–188
Candiano G, Bruschi M, Musante L, Santucci L, Ghiggeri GM, Carnemolla B et al (2004) Blue silver: a very sensitive colloidal Coomassie G-250 staining for proteome analysis. Electrophoresis 25:1327–1333
Kanno T, Yamada T, Iwabuki H, Tanaka H, Kuroda S, Tanizawa K et al (2002) Size distribution measurement of vesicles by atomic force microscopy. Anal Biochem 309:196–199
McEvoy M, Razinkov V, Wei Z, Casas-Finet JR, Tous GI, Schenerman MA (2011) Improved particle counting and size distribution determination of aggregated virus populations by asymmetric flow field-flow fractionation and multiangle light scattering techniques. Biotechnol Prog 27:547–554
Acknowledgments
We are grateful to C. Gurramkonda for critical comments.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Zahid, M., Rinas, U. (2019). Guidelines for Small-Scale Production and Purification of Hepatitis B Surface Antigen Virus-Like Particles from Recombinant Pichia pastoris . In: Gasser, B., Mattanovich, D. (eds) Recombinant Protein Production in Yeast. Methods in Molecular Biology, vol 1923. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-9024-5_14
Download citation
DOI: https://doi.org/10.1007/978-1-4939-9024-5_14
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-9023-8
Online ISBN: 978-1-4939-9024-5
eBook Packages: Springer Protocols